Collectively, this data can enable breakthroughs in digital diagnostics and therapeutics to solve some of the biggest health-care challenges humanity faces today.
The American pharmaceuticals giant Bristol Myers Squibb has announced plans to acquire the cancer drug therapeutics group Celgene in the 74-billion-dollar deal.
Last month, the WHO launched an international collaboration to accelerate the development, production and equitable distribution of vaccines, diagnostics, and therapeutics for COVID-19.